Görg C, Adler G, Görg K, Pflüger K H, Havemann K
Zentrum für Innere Medizin der Philipps-Universität, Abteilung Hämatologie/Onkologie/Immunologie, Marburg, Federal Republic of Germany.
J Cancer Res Clin Oncol. 1988;114(3):312-6. doi: 10.1007/BF00405841.
We report on a 47-year-old male patient with IgA-kappa plasmacytoma, who 12 months subsequent to diagnosis developed marked ascites. On light and electron microscopy morphologically identical plasma cells with bizarre intracytoplasmatic material were found in the bone marrow, pleural exudate, and ascites fluid. This kind of extramedullary spread is extremely rare and usually resists therapy. The mean survival rate for the 9 patients with malignant plasmacellular ascites whose cases have been documented so far was 2 months. After progression under VCMP regimens our patient has been successfully treated over a period of more than 4 years with i.v. VP16 monotherapy with additional intermittent local administration of methotrexate and systemic poly-chemotherapy according to the VAD scheme.
我们报告一例47岁的男性IgA-κ型浆细胞瘤患者,该患者在诊断后12个月出现明显腹水。在光镜和电镜下,在骨髓、胸腔渗出液和腹水中发现了形态相同且带有奇异胞浆内物质的浆细胞。这种髓外扩散极为罕见,且通常对治疗耐药。迄今为止,有文献记载的9例恶性浆细胞性腹水患者的平均生存率为2个月。在VCMP方案治疗病情进展后,我们的患者接受静脉注射VP16单药治疗,并额外间歇局部给予甲氨蝶呤,同时根据VAD方案进行全身多药化疗,成功治疗了4年多。